Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Leukemia, Myeloid, Acute 3Lymphoma, Non-Hodgkin 2Carcinoma, Basal Cell 2Breast Diseases 2Basal Cell Nevus Syndrome 2Upper Tract Urothelial Carcinomas 1Thrombocythemia, Essential 1Solid Tumors 1Serous Ovarian Cancer 1Recurrence 1Postmenopausal Women With ER+ HER2- Primary Breast Cancer 1Polycythemia Vera 1Ovarian Neoplasms 1Lymphedema 1Leukemia 1Immunoglobulin Light-chain Amyloidosis 1Hypogonadism 1Glioma 1Gastric Adenocarcinoma 1Fatigue Syndrome, Chronic 1Eunuchism 1Colorectal Neoplasms 1Amyloidosis 1Adenoma 1

Interventions

Colonoscopy 16Water 3Aspirin 3Ursodeoxycholic Acid 2Sunitinib 2Narrow Band Imaging 2Folic Acid 2Endoscopic Mucosal Resection 2Calcium Carbonate 2pegvisomant 1defactinib 1S-Adenosylmethionine 1Reference Standards 1Polyethylene Glycols 1Octreotide 1Occult Blood 1Methods 1Mesalamine 1Mass Screening 1Injections 1Indocyanine Green 1Endoscopy 1Drug Evaluation 1Diet, Fat-Restricted 1Diagnostic Tests, Routine 1Cholecystectomy 1Cholecalciferol 1Celecoxib 1Calcitriol 1Cabergoline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenoma × Drug Evaluation × Clear all
NCT02032784 2020-07-16

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

AdventHealth

Phase 4 Terminated
33 enrolled

Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡